13D/13G Filings - RA CAPITAL MANAGEMENT L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...22, 23, 24, 25, 26, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
4:39 pm
Purchase
2020-12-31 13G BCTG Acquisition Corp.
BCTG
RA CAPITAL MANAGEMENT L.P. 1,250,000
5.800%
1,250,000increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Dyne Therapeutics, Inc.
DYN
RA CAPITAL MANAGEMENT L.P. 2,805,045
6.200%
2,805,045increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Adverum Biotechnologies, Inc.
ADVM
RA CAPITAL MANAGEMENT L.P. 950,238
9.700%
950,238increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Frazier Lifesciences Acquisition Corporation
FLAC
RA CAPITAL MANAGEMENT L.P. 1,000,000
7.000%
1,000,000increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Geron Corporation
GERN
RA CAPITAL MANAGEMENT L.P. 31,114,941
9.990%
31,114,941increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Helix Acquisition Corp.
HLXA
RA CAPITAL MANAGEMENT L.P. 700,000
5.900%
700,000increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G ImmunoGen, Inc.
IMGN
RA CAPITAL MANAGEMENT L.P. 18,417,458
9.800%
18,417,458increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G FIVE PRIME THERAPEUTICS INC
FPRX
RA CAPITAL MANAGEMENT L.P. 4,285,161
9.800%
4,285,161increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Inhibrx Biosciences, Inc.
INBX
RA CAPITAL MANAGEMENT L.P. 2,129,003
5.600%
2,129,003increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Kinnate Biopharma Inc.
KNTE
RA CAPITAL MANAGEMENT L.P. 3,593,052
8.300%
3,593,052increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Inozyme Pharma, Inc.
INZY
RA CAPITAL MANAGEMENT L.P. 2,003,653
8.600%
2,003,653increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Larimar Therapeutics, Inc.
LRMR
RA CAPITAL MANAGEMENT L.P. 1,515,151
9.900%
1,515,151increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Akouos, Inc.
AKUS
RA CAPITAL MANAGEMENT L.P. 2,281,249
6.600%
2,281,249increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Lyra Therapeutics, Inc.
LYRA
RA CAPITAL MANAGEMENT L.P. 16,317
6.300%
16,317increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G MacroGenics, Inc.
MGNX
RA CAPITAL MANAGEMENT L.P. 4,375,217
7.800%
4,375,217increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Olema Pharmaceuticals, Inc.
OLMA
RA CAPITAL MANAGEMENT L.P. 2,150,404
5.400%
2,150,404increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G PANDION THERAPEUTICS INC
PAND
RA CAPITAL MANAGEMENT L.P. 1,770,023
6.000%
1,770,023increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Milestone Pharmaceuticals Inc.
MIST
RA CAPITAL MANAGEMENT L.P. 2,327,714
7.800%
2,327,714increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Trillium Therapeutics Inc.
TRIL
RA CAPITAL MANAGEMENT L.P. 5,290,481
5.300%
5,290,481increase
(New Position)
Filing
History
2021-02-16
4:39 pm
Purchase
2020-12-31 13G Ardelyx, Inc.
ARDX
RA CAPITAL MANAGEMENT L.P. 24,652,344
6.800%
2,543,992increase
(+11.51%)
Filing
History
Goto Prev, 0, 1, ...22, 23, 24, 25, 26, Next